Literature DB >> 18549840

Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke.

Daniel A Enquobahrie1, Nicholas L Smith, Joshua C Bis, Cara L Carty, Kenneth M Rice, Thomas Lumley, Lucia A Hindorff, Rozenn N Lemaitre, Michelle A Williams, David S Siscovick, Susan R Heckbert, Bruce M Psaty.   

Abstract

Variations in candidate genes participating in oxidative stress, inflammation, and their interactions are potentially associated with diseases of atherosclerotic origin. We investigated independent and joint associations of variations in cholesterol ester transfer protein (CETP), interleukin-8 (IL8), peroxisome proliferator activator receptor-alpha (PPARA), and Toll-like receptor 4 (TLR4) genes with incident nonfatal myocardial infarction (MI) or ischemic stroke. In a population-based case-control study, patients (848 with MI and 368 with ischemic stroke) and controls (2,682) were recruited from postmenopausal women and hypertensive men/women who were members of Group Health in western Washington State. Common tag single-nucleotide polymorphisms (SNPs; n=34) representing gene-wide variations were selected from gene sequencing data using pairwise linkage disequilibrium. Haplotypes were inferred using a modified expectation maximization algorithm. Multivariate logistic regression evaluated individual haplotype and SNP-disease associations in log-additive models. Global haplotype tests assessed overall gene-disease associations. Logic regression was used to evaluate gene-gene interactions. False discovery rates and permutation tests were used for multiple testing adjustment in evaluating independent associations and interactions, respectively. Overall, gene-wide variations in PPARA and TLR4 genes were associated with MI. The minor allele of the PPARA SNP, rs4253623, was associated with a higher risk of MI (odds ratio 1.25, 95% confidence interval 1.08 to 1.46), whereas the minor allele of the TLR4 SNP, rs1927911, was associated with a lower risk of MI (odds ratio 0.88, 95% confidence interval 0.77 to 0.99). No within-gene or gene-gene interaction was associated with MI or ischemic stroke risk. In conclusion, potential SNP-disease associations identified in the present study are novel and need further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549840      PMCID: PMC2577871          DOI: 10.1016/j.amjcard.2008.02.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

1.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

Review 2.  Genetic basis of atherosclerosis: part I: new genes and pathways.

Authors:  Aldons J Lusis; Alan M Fogelman; Gregg C Fonarow
Journal:  Circulation       Date:  2004-09-28       Impact factor: 29.690

Review 3.  Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.

Authors:  Anke H E M Klerkx; Karim El Harchaoui; Wim A van der Steeg; S Matthijs Boekholdt; Erik S G Stroes; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-26       Impact factor: 8.311

4.  Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study.

Authors:  E S Tai; S Demissie; L A Cupples; D Corella; P W Wilson; E J Schaefer; J M Ordovas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

5.  Interleukin-8 as a sensitive marker of unstable coronary artery disease.

Authors:  T Kanda; Y Hirao; S Oshima; K Yuasa; K Taniguchi; R Nagai; I Kobayashi
Journal:  Am J Cardiol       Date:  1996-02-01       Impact factor: 2.778

6.  Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction.

Authors:  John W Holloway; Ian A Yang; Shu Ye
Journal:  Pharmacogenet Genomics       Date:  2005-01       Impact factor: 2.089

7.  Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.

Authors:  Matthew J Kolek; John F Carlquist; Joseph B Muhlestein; Bryant M Whiting; Benjamin D Horne; Tami L Bair; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2004-12       Impact factor: 4.749

8.  Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis.

Authors:  Robert Y L Zee; Hillary H Hegener; Jessica Gould; Paul M Ridker
Journal:  Stroke       Date:  2004-12-02       Impact factor: 7.914

9.  Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.

Authors:  Nejma Ameziane; Tiphaine Beillat; Patrice Verpillat; Sylvie Chollet-Martin; Marie-Claude Aumont; Patrick Seknadji; Maryse Lamotte; Dominique Lebret; Véronique Ollivier; Dominique de Prost
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-16       Impact factor: 8.311

10.  IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.

Authors:  S Matthijs Boekholdt; Ron J G Peters; C Erik Hack; Nicholas E Day; Robert Luben; Sheila A Bingham; Nicholas J Wareham; Pieter H Reitsma; Kay-Tee Khaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

View more
  22 in total

1.  Association of Toll-like receptor 2 polymorphisms with National Institute of Health Stroke Scale scores of ischemic stroke patients.

Authors:  Hae Jeong Park; Su Kang Kim; Dong Hwan Yun; Dong Hwan Kim; Jinmann Chon; Jong Woo Kim; Joo-Ho Chung
Journal:  J Mol Neurosci       Date:  2011-09-02       Impact factor: 3.444

2.  PPARα gene polymorphisms modulate the association between physical activity and cardiometabolic risk.

Authors:  I Halder; J Champlin; L Sheu; B H Goodpaster; S B Manuck; R E Ferrell; M F Muldoon
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-03-01       Impact factor: 4.222

3.  Association between PPARs Gene Functional Polymorphisms and Ischemic Stroke in Chinese Uyghur Population.

Authors:  Y Tong; L Cai; Z Wang; Y Zhang; X Guan; F Zhan; J Liu; Q Lu
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

4.  Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study.

Authors:  Suzette J Bielinski; Jennifer L Hall; James S Pankow; Eric Boerwinkle; Nena Matijevic-Aleksic; Max He; Lloyd Chambless; Aaron R Folsom
Journal:  Hum Genet       Date:  2011-02-06       Impact factor: 4.132

5.  Carotid plaque and candidate genes related to inflammation and endothelial function in Hispanics from northern Manhattan.

Authors:  Hannah Gardener; Ashley Beecham; Digna Cabral; Danielle Yanuck; Susan Slifer; Liyong Wang; Susan H Blanton; Ralph L Sacco; Suh-Hang Hank Juo; Tatjana Rundek
Journal:  Stroke       Date:  2011-03-10       Impact factor: 7.914

6.  Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).

Authors:  Madeleine V Pahl; Zhenmin Ni; Lili Sepassi; Hamid Moradi; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

7.  Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function.

Authors:  Jyh-Ming Jimmy Juang; Lisa de Las Fuentes; Alan D Waggoner; C Charles Gu; Víctor G Dávila-Román
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

8.  Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke.

Authors:  Lucia A Hindorff; Rozenn N Lemaitre; Nicholas L Smith; Joshua C Bis; Kristin D Marciante; Kenneth M Rice; Thomas Lumley; Daniel A Enquobahrie; Guo Li; Susan R Heckbert; Bruce M Psaty
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

9.  TLR4 polymorphisms affect stroke risk and inflammatory response in Chinese ischemic stroke patients.

Authors:  Lian Gu; Jingyan Huang; Baoyun Liang; Qing Chen; Juanjuan Xie; Junwei Yang; Yan Yan; Qianli Tang
Journal:  Neurol Sci       Date:  2017-10-26       Impact factor: 3.307

10.  Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke.

Authors:  Satrupa Das; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  J Mol Neurosci       Date:  2017-09-30       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.